Evaluation of Serum Galectin-1, Galectin-3, Galectin-8, and Galectin-9 Levels in Children with Attention-deficit/Hyperactivity Disorder

Objective: Although the etiology of attention-deficit/hyperactivity disorder (ADHD) remains incompletely understood, evidence suggests an association between inflammatory processes and ADHD. Galectin-1, -3, -8, and -9 are involved in inflammatory and central nervous system processes. However, galectin-1, -8, and -9 have not been investigated in ADHD, and findings for galectin-3 are inconsistent. This study compared serum levels of galectin-1, -3, -8, and -9 between children with ADHD and controls and examined associations with symptom severity. Methods: The study included 45 children with ADHD and 40 age- and sex-matched controls aged 6−12 years. The ADHD diagnosis was made according to Diagnostic and Statistical Manual of Mental Disorders, fifth edition criteria. Symptom severity was assessed using the Conners’ Parent Rating Scale-Revised Short Form and, in the ADHD group, the Conners’ Teacher Rating Scale-Revised Short Form. Serum galectin-1, -3, -8, and -9 levels were measured using enzyme-linked immunosorbent assay. Results: Serum galectin-1 and galectin-9 levels were significantly higher, whereas galectin-8 levels were significantly lower in the ADHD group. Galectin-3 levels did not differ between groups. These group differences remained statistically significant after controlling for potential confounding variables. No correlations between galectin levels and ADHD symptom severity remained significant after Bonferroni correction. Receiver operating characteristic analysis showed significant discriminative performance for galectin-1 (area under the curve [AUC] = 0.738), galectin-8 (AUC = 0.835), and galectin-9 (AUC = 0.714), but not galectin-3. Conclusion: Altered serum galectin-1, galectin-8, and galectin-9 levels may be associated with ADHD. These preliminary findings require validation in larger, independent, longitudinal studies.

Authors

Institutions

Publication Details

Journal
Clinical Psychopharmacology and Neuroscience
Published
2026-11-18
DOI
https://doi.org/10.9758/cpn.26.1477
Primary Topic
Attention Deficit Hyperactivity Disorder
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of Serum Galectin-1, Galectin-3, Galectin-8, and Galectin-9 Levels in Children with Attention-deficit/Hyperactivity Disorder

Nihal Türkmen Alemdar, Esra Hoşoğlu, Yüksel Aliyazıcıoğlu, Bahadır Turan et al.
2 links
Clinical Psychopharmacology and Neuroscience
Attention Deficit Hyperactivity Disorder
article

Evaluation of Serum Galectin-1, Galectin-3, Galectin-8, and Galectin-9 Levels in Children with Attention-deficit/Hyperactivity Disorder

Nihal Türkmen Alemdar, Esra Hoşoğlu, Yüksel Aliyazıcıoğlu, Bahadır Turan, Züleyha Ulusoy
article en

Abstract

Objective: Although the etiology of attention-deficit/hyperactivity disorder (ADHD) remains incompletely understood, evidence suggests an association between inflammatory processes and ADHD. Galectin-1, -3, -8, and -9 are involved in inflammatory and central nervous system processes. However, galectin-1, -8, and -9 have not been investigated in ADHD, and findings for galectin-3 are inconsistent. This study compared serum levels of galectin-1, -3, -8, and -9 between children with ADHD and controls and examined associations with symptom severity. Methods: The study included 45 children with ADHD and 40 age- and sex-matched controls aged 6−12 years. The ADHD diagnosis was made according to Diagnostic and Statistical Manual of Mental Disorders, fifth edition criteria. Symptom severity was assessed using the Conners’ Parent Rating Scale-Revised Short Form and, in the ADHD group, the Conners’ Teacher Rating Scale-Revised Short Form. Serum galectin-1, -3, -8, and -9 levels were measured using enzyme-linked immunosorbent assay. Results: Serum galectin-1 and galectin-9 levels were significantly higher, whereas galectin-8 levels were significantly lower in the ADHD group. Galectin-3 levels did not differ between groups. These group differences remained statistically significant after controlling for potential confounding variables. No correlations between galectin levels and ADHD symptom severity remained significant after Bonferroni correction. Receiver operating characteristic analysis showed significant discriminative performance for galectin-1 (area under the curve [AUC] = 0.738), galectin-8 (AUC = 0.835), and galectin-9 (AUC = 0.714), but not galectin-3. Conclusion: Altered serum galectin-1, galectin-8, and galectin-9 levels may be associated with ADHD. These preliminary findings require validation in larger, independent, longitudinal studies.

Clinical Psychopharmacology and Neuroscience
Ministry of Health (TR), Recep Tayyip Erdoğan University (TR), Karadeniz Technical University (TR)
Karadeniz Teknik Üniversitesi
Good health and well-being
Attention Deficit Hyperactivity Disorder
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon